Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| LQDA | CLUSTER | neutral | 3/10 | Multiple C-suite executives at Liquidia Corp, including the CFO and Chief Business Officer, sold shares in a coordinated | Mar 3, 2026 |
| KPTI | CLUSTER | neutral | 3/10 | KPTI insiders sold a combined $164K in open-market transactions over the past week, including CEO Richard Paulson and EV | Mar 3, 2026 |
| VRTX | CLUSTER | neutral | 3/10 | Seven executives at Vertex Pharmaceuticals sold shares in a coordinated cluster over a 3-day window, with total open-mar | Mar 3, 2026 |
| NTLA | CLUSTER | neutral | 3/10 | Intellia Therapeutics insiders executed a mix of open-market sales and stock awards over the past week. Two executives s | Mar 3, 2026 |
| ALEC | CLUSTER | neutral | 3/10 | Two Alector executives, the CFO and Principal Accounting Officer, sold shares in the past week, totaling $73,151 in open | Mar 3, 2026 |
| VIR | CLUSTER | bearish | 5/10 | Three corporate insiders at Vir Biotechnology sold shares in the past seven days, including two executives who sold a co | Mar 3, 2026 |
| FBLG | CLUSTER | neutral | 3/10 | Two corporate insiders at FibroBiologics, Inc. (FBLG), the CFO and General Counsel, purchased shares in the open market | Mar 3, 2026 |
| ARVN | CLUSTER | neutral | 3/10 | An insider at Arvinas, Inc. (ARVN) sold 4,688 shares in an open-market transaction, generating proceeds of approximately | Mar 2, 2026 |
| LRMR | CLUSTER | bullish | 8/10 | Four insiders at Larimar Therapeutics collectively purchased $6.07 million in shares over a single day at $5 per share, | Mar 2, 2026 |
| GENB | CLUSTER | neutral | 3/10 | A cluster of insider transactions at Generate Biomedicines (GENB) over the past week includes two open-market purchases | Mar 2, 2026 |
| OVID | CLUSTER | neutral | 2/10 | Ovid Therapeutics' Chief Business and Financial Officer, Rona Jeffrey A, was granted 68,125 shares as a non-cash award. | Mar 2, 2026 |
| LRMR | CLUSTER | bullish | 6/10 | Three insiders at Larimar Therapeutics collectively purchased $550,000 worth of shares in open-market transactions on Fe | Mar 2, 2026 |
| ABCL | CLUSTER | bullish | 6/10 | Two insiders at AbCellera Biologics purchased shares in the open market within the same week, including CFO Andrew Booth | Mar 2, 2026 |
| PVLA | CLUSTER | bullish | 6/10 | Two insiders at Palvella Therapeutics, Inc. (PVLA) made open-market purchases totaling $800,000 within the past week, bu | Mar 2, 2026 |
| ACLX | CLUSTER | bearish | 7/10 | Two corporate insiders at Arcellx, Inc. (ACLX) sold shares in the past week, including CFO Michelle Gilson, who sold ove | Feb 27, 2026 |
| QTTB | CLUSTER | neutral | 3/10 | Three executive insiders at Q32 Bio Inc. (QTTB) sold shares in a coordinated open-market transaction on February 25, 202 | Feb 27, 2026 |
| QURE | CLUSTER | neutral | 4/10 | Two top executives at uniQure, the CEO and CFO, sold shares in a coordinated open-market transaction, generating nearly | Feb 27, 2026 |
| CRBU | CLUSTER | neutral | 3/10 | Five C-suite executives at Caribou Biosciences sold shares in a coordinated 7-day window, generating $47,474 in total pr | Feb 27, 2026 |
| BMRN | CLUSTER | neutral | 4/10 | Two senior executives at BioMarin Pharmaceutical sold shares in the past week, with total open-market proceeds of approx | Feb 26, 2026 |
| VRTX | CLUSTER | neutral | 4/10 | Seven Vertex Pharmaceuticals executives sold shares in the past week, including open-market sales totaling $2.3M and tax | Feb 26, 2026 |
| VRTX | CLUSTER | neutral | 3/10 | Two executives at Vertex Pharmaceuticals executed open-market share sales totaling $433K, while the same insiders also s | Feb 26, 2026 |
| CGEM | CLUSTER | bearish | 5/10 | Six open-market share sales by Cullinan Therapeutics insiders over the past seven days, including the CEO, CMO, CSO, and | Feb 26, 2026 |
| VIR | CLUSTER | bearish | 5/10 | Multiple C-suite executives at Vir Biotechnology, including the CEO, CFO, and General Counsel, conducted open-market sha | Feb 26, 2026 |
| VYGR | CLUSTER | bearish | 6/10 | Four executive insiders at Voyager Therapeutics (VYGR), including the CEO, COO, CFO, and Chief Scientific Officer, colle | Feb 26, 2026 |
| VYGR | CLUSTER | bearish | 6/10 | Three top executives at Voyager Therapeutics, the CEO, CFO, and Chief Scientific Officer, collectively sold over $87,000 | Feb 26, 2026 |
| CGEM | CLUSTER | bearish | 6/10 | Five corporate insiders at Cullinan Therapeutics (CGEM), including the CEO, CLO, CMO, and CSO, sold shares in a coordina | Feb 26, 2026 |
| TWST | CLUSTER | bearish | 6/10 | Six insiders at Twist Bioscience Corp, including the CEO, COO, CFO, and other executives, sold shares in a coordinated o | Feb 26, 2026 |
| IRWD | CLUSTER | bearish | 6/10 | Six open-market share sales by three C-suite executives at Ironwood Pharmaceuticals (IRWD) over the past seven days tota | Feb 26, 2026 |
| VERA | CLUSTER | bearish | 8/10 | Seven corporate insiders at Vera Therapeutics, including the CEO, CFO, and other C-suite executives, collectively sold o | Feb 26, 2026 |
| OCUL | CLUSTER | mixed | 5/10 | A cluster of insider transactions at Ocular Therapeutix (OCUL) shows mixed activity: one significant open-market purchas | Feb 26, 2026 |